These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparisons in fluctuation of muscle strength and function in patients with immune-mediated neuropathy treated with intravenous versus subcutaneous immunoglobulin. Christiansen I; Markvardsen LH; Jakobsen J Muscle Nerve; 2018 Apr; 57(4):610-614. PubMed ID: 28881389 [TBL] [Abstract][Full Text] [Related]
5. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin. Cirillo G; Todisco V; Tedeschi G Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS; Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. Eftimov F; Vermeulen M; de Haan RJ; van den Berg LH; van Schaik IN J Peripher Nerv Syst; 2009 Jun; 14(2):93-100. PubMed ID: 19691531 [TBL] [Abstract][Full Text] [Related]
8. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA; Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948 [TBL] [Abstract][Full Text] [Related]
9. Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. Markvardsen LH; Christiansen I; Jakobsen J Transfusion; 2016 Oct; 56(10):2443-2448. PubMed ID: 27401495 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. van Schaik IN; Bril V; van Geloven N; Hartung HP; Lewis RA; Sobue G; Lawo JP; Praus M; Mielke O; Durn BL; Cornblath DR; Merkies ISJ; Lancet Neurol; 2018 Jan; 17(1):35-46. PubMed ID: 29122523 [TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years. Gentile L; Mazzeo A; Russo M; Arimatea I; Vita G; Toscano A Sci Rep; 2020 May; 10(1):7910. PubMed ID: 32404895 [TBL] [Abstract][Full Text] [Related]
12. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749 [TBL] [Abstract][Full Text] [Related]
13. Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. Vanhoutte EK; Latov N; Deng C; Hanna K; Hughes RA; Bril V; Dalakas MC; Donofrio P; van Doorn PA; Hartung HP; Merkies IS Eur J Neurol; 2013 May; 20(5):748-55. PubMed ID: 22891893 [TBL] [Abstract][Full Text] [Related]
14. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy. Harbo T; Andersen H; Jakobsen J Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876 [TBL] [Abstract][Full Text] [Related]
15. Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin. Ryltoft AK; Al-Zuhairy A; Sindrup SH; Andersen H; Markvardsen LK Acta Neurol Scand; 2020 Dec; 142(6):637-640. PubMed ID: 33404110 [TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Harbo T; Andersen H; Jakobsen J Neurology; 2010 Oct; 75(15):1377-80. PubMed ID: 20938030 [TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin. Markvardsen LH; Vaeggemose M; Ringgaard S; Andersen H Neuroradiology; 2016 Aug; 58(8):745-52. PubMed ID: 27114080 [TBL] [Abstract][Full Text] [Related]
20. IgPro20, the Polyneuropathy and Treatment with Hizentra Berger M; Harbo T; Cornblath DR; Mielke O Immunotherapy; 2018 Aug; 10(11):919-933. PubMed ID: 29764262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]